Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Intro highlights steps to build credit with a secured card while avoiding debt, emphasizing payment discipline and utilization management.
22,663 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A tentative Department of Justice settlement keeps Live Nation's Ticketmaster in place but imposes reforms that could...
A large Bitcoin transfer to Gemini has reignited questions about whether the Winklevoss twins are selling BTC. Arkham...
ResMed stock often sits on the radar, but three solid factors suggest it deserves closer attention. This practical gu...
Markets pivot as reports say iran’s supreme leader injured; investors reassess oil supply risk, sanctions, and possib...
Bitcoin steadies as options traders bitcoin reclaiming the $80,000 threshold rise, with inflation cooling and geopoli...
As Costco’s sales momentum stays strong, investors wonder if the stock can keep delivering. This guide breaks down th...
Internal investigators allege Binance processed more than $1 billion in transfers to Iran-linked entities, centering ...
Rivian unveils the R2 with a sub-$45k price target and near-term shipments, while Lucid battles cash burn and no 2026...
Regulators move toward a sweeping U.S. crypto framework, boosting risk assets and shaping near-term price moves. Bitc...
A sharp 87% drop in February crypto losses belies a pivot by attackers toward social engineering and user-targeted sc...
Institutional buyers returned to digital assets in force, with BlackRock at the helm, buying roughly $600 million in ...